116 related articles for article (PubMed ID: 37137344)
21. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
22. Abbreviated screening protocol for breast MRI: a feasibility study.
Grimm LJ; Soo MS; Yoon S; Kim C; Ghate SV; Johnson KS
Acad Radiol; 2015 Sep; 22(9):1157-62. PubMed ID: 26152500
[TBL] [Abstract][Full Text] [Related]
23. Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response?
D'Angelo A; Orlandi A; Bufi E; Mercogliano S; Belli P; Manfredi R
Radiol Med; 2021 Apr; 126(4):517-526. PubMed ID: 33385300
[TBL] [Abstract][Full Text] [Related]
24. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
25. A new algorithm for automatic vascular mapping of DCE-MRI of the breast: Clinical application of a potential new biomarker.
Vignati A; Giannini V; Carbonaro LA; Bertotto I; Martincich L; Sardanelli F; Regge D
Comput Methods Programs Biomed; 2014 Dec; 117(3):482-8. PubMed ID: 25262335
[TBL] [Abstract][Full Text] [Related]
26. Value of ultrafast and standard dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the presence and extension of residual disease after neoadjuvant chemotherapy in breast cancer.
Kato E; Mori N; Mugikura S; Sato S; Ishida T; Takase K
Jpn J Radiol; 2021 Aug; 39(8):791-801. PubMed ID: 33743147
[TBL] [Abstract][Full Text] [Related]
27. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
[TBL] [Abstract][Full Text] [Related]
30. Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multidetector-row CT and dynamic MRI.
Tozaki M; Uno S; Kobayashi T; Aiba K; Yoshida K; Takeyama H; Shioya H; Tabei I; Toriumi Y; Suzuki M; Kawakami M; Fukuda K
Radiat Med; 2004; 22(4):246-53. PubMed ID: 15468945
[TBL] [Abstract][Full Text] [Related]
31. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
[TBL] [Abstract][Full Text] [Related]
32. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
[TBL] [Abstract][Full Text] [Related]
33. Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence.
Milon A; Vande Perre S; Poujol J; Trop I; Kermarrec E; Bekhouche A; Thomassin-Naggara I
Eur J Radiol; 2019 Aug; 117():199-208. PubMed ID: 31307648
[TBL] [Abstract][Full Text] [Related]
34. Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes.
Kim J; Han BK; Ko EY; Ko ES; Choi JS; Park KW
Eur Radiol; 2022 Jun; 32(6):4056-4066. PubMed ID: 34989844
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features.
Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
AJR Am J Roentgenol; 2019 Oct; 213(4):944-952. PubMed ID: 31237439
[No Abstract] [Full Text] [Related]
36. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy.
Henderson SA; Muhammad Gowdh N; Purdie CA; Jordan LB; Evans A; Brunton T; Thompson AM; Vinnicombe S
Br J Radiol; 2018 Jul; 91(1087):20180123. PubMed ID: 29641224
[TBL] [Abstract][Full Text] [Related]
38. Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
Wu WP; Wu HK; Chen CJ; Lee CW; Chen ST; Chen DR; Chou CT; Mok CW; Lai HW
PLoS One; 2019; 14(10):e0222917. PubMed ID: 31600220
[TBL] [Abstract][Full Text] [Related]
39. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
Li Z; Li J; Lu X; Qu M; Tian J; Lei J
Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
